Women's Health

News on women's health diagnostics, including prenatal testing, STD testing, and cancer testing

The contract includes a milestone of approval by the Chinese Food and Drug Agency within the next three years.

The planned test will be based on LifeCodexx's methylation-specific quantitative PCR technology.

The test will be developed in Global Good labs and ported onto QuantuMDx's handheld molecular platform.

The firm is launching the test for bacterial vaginosis in Europe, the Middle East, and North Africa. 

The firm said that it planned to lay off its oncology sales team in order to focus on women's health, despite launching an oncology business unit last spring.